Announcements Trials
Browse Landscape

Phase

Phase NA 14Phase 3 2Phase 2 1

Status

Completed 11Recruiting 3Active not recruiting 3Unknown 2

Sponsor Class

NIH 1NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other 1Gynecologic 1Breast 1

Conditions

Obesity 1Fallopian Tube Neoplasms 1Brenner Tumor 1Breast Neoplasms 1Body Weight Changes 1

Interventions

Cisplatin 130Radiotherapy 94Carboplatin 85Paclitaxel 78Fluorouracil 78Cyclophosphamide 77Gemcitabine 72Capecitabine 66Docetaxel 65Doxorubicin 60Oxaliplatin 59Etoposide 57Leucovorin 49Vincristine 47Chemotherapy, Adjuvant 42Cytarabine 38Dexamethasone 35Drug Therapy 33Bevacizumab 30Epirubicin 29Neoadjuvant Therapy 28Pemetrexed 27Tamoxifen 25Prednisone 24Irinotecan 24Rituximab 21Methotrexate 21Radiotherapy, Intensity-Modulated 19apatinib 18Vinorelbine 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Unknown × Early Intervention, Educational × Clear all
NCT00719303 2018-02-19

Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

GOG Foundation

Phase 3 Unknown
1,070 enrolled
Gynecologic

Brenner Tumor, Fallopian Tube Neoplasms

NCT00859989 2013-12-18

A Weight-Loss Program in Helping Obese Black Women Lose Weight

National Cancer Institute (NCI)

Phase 3 Unknown
200 enrolled
BreastOther

Body Weight Changes, Breast Neoplasms, Obesity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡